APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologics Monoclonal Antibodies Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biologics Monoclonal Antibodies Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173970760321 December 2025194 pages

Choose your research edition.

Industry ResearchBiologics Monoclonal Antibodies Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Monoclonal Antibodies Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologics Monoclonal Antibodies Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Monoclonal Antibodies Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics Monoclonal Antibodies Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Biologics Monoclonal Antibodies Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biologics Monoclonal Antibodies Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologics Monoclonal Antibodies Drug include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer, Biogen and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biologics Monoclonal Antibodies Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologics Monoclonal Antibodies Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologics Monoclonal Antibodies Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biologics Monoclonal Antibodies Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologics Monoclonal Antibodies Drug Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Biogen

Amgen

AbbVie

Sobi

Innovent Biologics

Biologics Monoclonal Antibodies Drug Segment by Type

Trastuzumab

Rituximab

Infliximab

Adalimumab

Other

Biologics Monoclonal Antibodies Drug Segment by Application

Cancer

Autoimmune Disease

Other

Biologics Monoclonal Antibodies Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Monoclonal Antibodies Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Monoclonal Antibodies Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Monoclonal Antibodies Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biologics Monoclonal Antibodies Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologics Monoclonal Antibodies Drug industry.

Chapter 3: Detailed analysis of Biologics Monoclonal Antibodies Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Monoclonal Antibodies Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Trastuzumab Table 3. Key Players of Rituximab Table 4. Key Players of Infliximab Table 3. Key Players of Adalimumab Table 4. Key Players of Other Table 5. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Cancer Table 7. Key Players of Autoimmune Disease Table 8. Key Players of Other Table 9. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Biologics Monoclonal Antibodies Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2021-2026) Table 12. Global Biologics Monoclonal Antibodies Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2027-2032) Table 14. Biologics Monoclonal Antibodies Drug Industry Trends Table 15. Biologics Monoclonal Antibodies Drug Industry Drivers Table 16. Biologics Monoclonal Antibodies Drug Industry Opportunities and Challenges Table 17. Biologics Monoclonal Antibodies Drug Industry Restraints Table 18. Global Biologics Monoclonal Antibodies Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Company (2021-2026) Table 20. Global Biologics Monoclonal Antibodies Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Biologics Monoclonal Antibodies Drug Key Company Head Office and Area Served Table 22. Global Biologics Monoclonal Antibodies Drug Company, Product Type & Application Table 23. Global Biologics Monoclonal Antibodies Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Biologics Monoclonal Antibodies Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Biologics Monoclonal Antibodies Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Type (2021-2026) Table 30. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Type (2027-2032) Table 31. Global Biologics Monoclonal Antibodies Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Application (2021-2026) Table 35. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Application (2027-2032) Table 36. Sanofi Company Information Table 37. Sanofi Business Overview Table 38. Sanofi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sanofi Biologics Monoclonal Antibodies Drug Product Portfolio Table 40. Sanofi Recent Development Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Novartis Company Information Table 47. Novartis Business Overview Table 48. Novartis Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Novartis Biologics Monoclonal Antibodies Drug Product Portfolio Table 50. Novartis Recent Development Table 51. Merck Company Information Table 52. Merck Business Overview Table 53. Merck Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Merck Biologics Monoclonal Antibodies Drug Product Portfolio Table 55. Merck Recent Development Table 56. Roche Company Information Table 57. Roche Business Overview Table 58. Roche Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Roche Biologics Monoclonal Antibodies Drug Product Portfolio Table 60. Roche Recent Development Table 61. Eli Lilly Company Information Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Eli Lilly Biologics Monoclonal Antibodies Drug Product Portfolio Table 65. Eli Lilly Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Pfizer Biologics Monoclonal Antibodies Drug Product Portfolio Table 70. Pfizer Recent Development Table 71. Biogen Company Information Table 72. Biogen Business Overview Table 73. Biogen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Biogen Biologics Monoclonal Antibodies Drug Product Portfolio Table 75. Biogen Recent Development Table 76. Amgen Company Information Table 77. Amgen Business Overview Table 78. Amgen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Amgen Biologics Monoclonal Antibodies Drug Product Portfolio Table 80. Amgen Recent Development Table 81. AbbVie Company Information Table 82. AbbVie Business Overview Table 83. AbbVie Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AbbVie Biologics Monoclonal Antibodies Drug Product Portfolio Table 85. AbbVie Recent Development Table 86. Sobi Company Information Table 87. Sobi Business Overview Table 88. Sobi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sobi Biologics Monoclonal Antibodies Drug Product Portfolio Table 90. Sobi Recent Development Table 91. Innovent Biologics Company Information Table 92. Innovent Biologics Business Overview Table 93. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Innovent Biologics Biologics Monoclonal Antibodies Drug Product Portfolio Table 95. Innovent Biologics Recent Development Table 96. North America Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 97. North America Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032) & (US$ Million) Table 98. North America Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 99. North America Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032) & (US$ Million) Table 100. North America Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) Table 102. North America Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032) Table 103. Europe Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 104. Europe Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032) & (US$ Million) Table 105. Europe Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 106. Europe Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032) & (US$ Million) Table 107. Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) Table 109. Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032) Table 110. China Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 111. China Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032) & (US$ Million) Table 112. China Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 113. China Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032) & (US$ Million) Table 114. Asia Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 115. Asia Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032) & (US$ Million) Table 116. Asia Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 117. Asia Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) Table 120. Asia Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032) Table 121. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026) & (US$ Million) Table 124. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032) & (US$ Million) Table 125. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026) Table 127. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Biologics Monoclonal Antibodies Drug Product Image Figure 2. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biologics Monoclonal Antibodies Drug Market Share by Type: 2025 VS 2032 Figure 4. Trastuzumab Image Figure 5. Rituximab Image Figure 6. Infliximab Image Figure 7. Adalimumab Image Figure 8. Other Image Figure 9. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Biologics Monoclonal Antibodies Drug Market Share by Application: 2025 VS 2032 Figure 11. Cancer Image Figure 12. Autoimmune Disease Image Figure 13. Other Image Figure 14. Global Biologics Monoclonal Antibodies Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global Biologics Monoclonal Antibodies Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Biologics Monoclonal Antibodies Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Biologics Monoclonal Antibodies Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Type (2021-2032) Figure 23. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032) Figure 27. North America Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032) Figure 28. North America Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 29. United States Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032) Figure 34. Europe Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032) Figure 35. Europe Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 36. Germany Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 37. France Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032) Figure 44. China Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032) Figure 45. Asia Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032) Figure 47. Asia Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032) Figure 48. Asia Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 49. Japan Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 53. India Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032) Figure 59. Brazil Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile Biologics Monoclonal Antibodies Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Trastuzumab
  • Rituximab
  • Infliximab
  • Adalimumab
  • Other
Applications
  • Cancer
  • Autoimmune Disease
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Biogen
  • Amgen
  • AbbVie
  • Sobi
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Trastuzumab
  5. 1.2.3 Rituximab
  6. 1.2.4 Infliximab
  7. 1.2.5 Adalimumab
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Cancer
  12. 1.3.3 Autoimmune Disease
  13. 1.3.4 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Biologics Monoclonal Antibodies Drug Growth Trends by Region
  16. 1.5.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Biologics Monoclonal Antibodies Drug Market Size by Region (2021-2026)
  18. 1.5.3 Biologics Monoclonal Antibodies Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Biologics Monoclonal Antibodies Drug Market Dynamics
  1. 2.1 Biologics Monoclonal Antibodies Drug Industry Trends
  2. 2.2 Biologics Monoclonal Antibodies Drug Industry Drivers
  3. 2.3 Biologics Monoclonal Antibodies Drug Industry Opportunities and Challenges
  4. 2.4 Biologics Monoclonal Antibodies Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biologics Monoclonal Antibodies Drug Revenue by Company (2021-2026)
  2. 3.2 Global Biologics Monoclonal Antibodies Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biologics Monoclonal Antibodies Drug Key Company Head office and Area Served
  4. 3.4 Global Biologics Monoclonal Antibodies Drug Company, Product Type & Application
  5. 3.5 Global Biologics Monoclonal Antibodies Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biologics Monoclonal Antibodies Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biologics Monoclonal Antibodies Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biologics Monoclonal Antibodies Drug Tier 1, Tier 2, and Tier 3
4 Biologics Monoclonal Antibodies Drug Market by Type
  1. 4.1 Global Biologics Monoclonal Antibodies Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2032)
  3. 4.3 Global Biologics Monoclonal Antibodies Drug Market Size Share by Type (2021-2032)
5 Biologics Monoclonal Antibodies Drug Market by Application
  1. 5.1 Global Biologics Monoclonal Antibodies Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2032)
  3. 5.3 Global Biologics Monoclonal Antibodies Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Biologics Monoclonal Antibodies Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Biologics Monoclonal Antibodies Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck Biologics Monoclonal Antibodies Drug Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Roche Biologics Monoclonal Antibodies Drug Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eli Lilly Biologics Monoclonal Antibodies Drug Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Biologics Monoclonal Antibodies Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biogen Biologics Monoclonal Antibodies Drug Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 Amgen
  50. 6.9.1 Amgen Company Information
  51. 6.9.2 Amgen Business Overview
  52. 6.9.3 Amgen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Amgen Biologics Monoclonal Antibodies Drug Product Portfolio
  54. 6.9.5 Amgen Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AbbVie Biologics Monoclonal Antibodies Drug Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Sobi
  62. 6.11.1 Sobi Company Information
  63. 6.11.2 Sobi Business Overview
  64. 6.11.3 Sobi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sobi Biologics Monoclonal Antibodies Drug Product Portfolio
  66. 6.11.5 Sobi Recent Developments
  67. 6.12 Innovent Biologics
  68. 6.12.1 Innovent Biologics Company Information
  69. 6.12.2 Innovent Biologics Business Overview
  70. 6.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Product Portfolio
  72. 6.12.5 Innovent Biologics Recent Developments
7 North America
  1. 7.1 North America Biologics Monoclonal Antibodies Drug Market Size (2021-2032)
  2. 7.2 North America Biologics Monoclonal Antibodies Drug Market Size by Type
  3. 7.2.1 North America Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032)
  6. 7.3 North America Biologics Monoclonal Antibodies Drug Market Size by Application
  7. 7.3.1 North America Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032)
  10. 7.4 North America Biologics Monoclonal Antibodies Drug Market Size by Country
  11. 7.4.1 North America Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biologics Monoclonal Antibodies Drug Market Size (2021-2032)
  2. 8.2 Europe Biologics Monoclonal Antibodies Drug Market Size by Type
  3. 8.2.1 Europe Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Biologics Monoclonal Antibodies Drug Market Size by Application
  7. 8.3.1 Europe Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Biologics Monoclonal Antibodies Drug Market Size by Country
  11. 8.4.1 Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biologics Monoclonal Antibodies Drug Market Size (2021-2032)
  2. 9.2 China Biologics Monoclonal Antibodies Drug Market Size by Type
  3. 9.2.1 China Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032)
  6. 9.3 China Biologics Monoclonal Antibodies Drug Market Size by Application
  7. 9.3.1 China Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biologics Monoclonal Antibodies Drug Market Size (2021-2032)
  2. 10.2 Asia Biologics Monoclonal Antibodies Drug Market Size by Type
  3. 10.2.1 Asia Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Biologics Monoclonal Antibodies Drug Market Size by Application
  7. 10.3.1 Asia Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Biologics Monoclonal Antibodies Drug Market Size by Country
  11. 10.4.1 Asia Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biologics Monoclonal Antibodies Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst